OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Facebook

RSS

Youtube

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva

Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X:

“EXCELLENT Blood Journal MajesTEC-1 analysis of response predictors in MMsm (Cortes-Selva et al).

Article focuses on T cells, mehh – I’ll focus on fascinating BCMA facts instead.

BCMA on BMPCs (flow) does NOT predict ORR.
Lower sBCMA is better.”

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

Authors: Diana Cortes-Selva, Tatiana Perova, Sheri Skerget, Deeksha Vishwamitra, Sarah Stein, Rengasamy Boominathan, Onsay Lau, Karl Calara-Nielsen, Cuc Davis, Jaymala Patel, Arnob Banerjee, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Jenna Goldberg, Lixia Pei, Danielle Trancucci, Suzette Girgis, Shun Xin Wang Lin, Liviawati S Wu, Philippe Moreau, Saad Z Usmani, Nizar J Bahlis, Niels W C J van de Donk, and Raluca I Verona.

Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva

For more information.

Source: Rahul Banerjee/X

Blood Journal cancer Diana Cortes-Selva MajesTEC-1 Niels W. C. J. van de Donk Nizar J Bahlis OncoDaily Oncology Rahul Banerjee Raluca I Verona Sheri Skerget Tatiana Perova

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Bernard Fox received SITC lifetime achievement award

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Special Coverage